Although long-term nursing home stay or death decreased before the COVID-19 pandemic, the trend slowed during the pandemic ...

The issue will feature guest editor Nate Apathy, Ph.D., from the University of Maryland School of Public Health in College ...

The design of the Enhancing Oncology Model (EOM) was a perfect fit for Minnesota Oncology.

Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at Mayo Clinic, suggests that medical providers can reduce patient ...

Extranodal non-Hodgkin lymphoma (NHL) makes up over one-third of NHL cases, yet remains understudied and in need of deeper ...

Panelists discuss how switching therapies in patients with alopecia areata (AA) is often necessary when initial treatments ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

The pause has raised concerns among health officials and state leaders, as the vague wording leaves billions in Medicaid ...

According to a review of hospital-based cross-sectional studies, almost half the type 2 diabetes population is micronutrient ...

First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...

According to the CDC, frequent consumption of sugary drinks is linked to adverse health outcomes that include obesity, type 2 ...